Quince Therapeutics, Inc.
QNCX
$34.04
$1.635.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.16M | 17.75M | 26.29M | 34.71M | 31.60M |
| Total Receivables | 6.56M | 3.62M | 995.00K | 992.00K | 916.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 836.00K | 890.00K | 1.07M | 527.00K | 758.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 24.00K | 632.00K | 845.00K | 1.12M | 556.00K |
| Total Current Assets | 25.58M | 22.90M | 29.20M | 37.35M | 33.83M |
|
|
|||||
| Total Current Assets | 25.58M | 22.90M | 29.20M | 37.35M | 33.83M |
| Net Property, Plant & Equipment | 965.00K | 1.05M | 1.10M | 1.08M | 941.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 67.82M | 463.00K | 67.57M | 62.37M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 1.68M | 79.06M | 11.14M | 9.88M |
| Total Assets | 26.62M | 93.52M | 109.90M | 117.21M | 107.09M |
|
|
|||||
| Total Accounts Payable | 5.39M | 2.22M | 3.40M | 1.76M | 3.01M |
| Total Accrued Expenses | 3.09M | 10.29M | 4.71M | 5.42M | 5.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 113.00K | 18.14M | 17.63M | 112.00K | 102.00K |
| Total Finance Division Other Current Liabilities | 176.00K | 12.58M | 295.00K | 180.00K | 233.00K |
| Total Other Current Liabilities | 176.00K | 12.58M | 295.00K | 180.00K | 233.00K |
| Total Current Liabilities | 8.77M | 43.23M | 26.04M | 7.47M | 8.36M |
|
|
|||||
| Total Current Liabilities | 8.77M | 43.23M | 26.04M | 7.47M | 8.36M |
| Long-Term Debt | -- | -- | -- | 16.99M | 15.27M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 293.00K | 330.00K | 359.00K | 387.00K | 383.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.89M | 85.68M | 82.44M | 80.63M | 64.50M |
| Total Liabilities | 10.95M | 129.24M | 108.84M | 105.47M | 88.51M |
|
|
|||||
| Common Stock & APIC | 435.60M | 418.99M | 415.76M | 413.13M | 408.13M |
| Retained Earnings | -424.54M | -460.45M | -420.99M | -407.55M | -391.50M |
| Treasury Stock & Other | 4.61M | 5.75M | 6.29M | 6.16M | 1.96M |
| Total Common Equity | 15.67M | -35.71M | 1.06M | 11.74M | 18.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 15.67M | -35.71M | 1.06M | 11.74M | 18.58M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.67M | -35.71M | 1.06M | 11.74M | 18.58M |
|
|
|||||